These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 15359871
1. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus]. Nagoshi S, Fujiwara K. Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871 [No Abstract] [Full Text] [Related]
6. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S. Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904 [Abstract] [Full Text] [Related]
8. [Epidemiology of hepatitis C virus and hepatocellular carcinoma in Japan]. Tanaka T, Hirota Y, Nishiguchi S. Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):611-4. PubMed ID: 15359870 [No Abstract] [Full Text] [Related]
9. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK. J Clin Gastroenterol; 2009 Jul; 43(5):482-8. PubMed ID: 19197197 [Abstract] [Full Text] [Related]
11. [Expert consensus on standardization of the management of primary liver cancer]. Ye SL. Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):403-10. PubMed ID: 19645134 [No Abstract] [Full Text] [Related]
12. [Changed diagnosis and treatment of hepatocellular carcinoma]. van Nieuwkerk CM, Rauws EA, Tytgat GN, Reeders JW, Jones AE, Gouma DJ. Ned Tijdschr Geneeskd; 1996 Apr 27; 140(17):922-6. PubMed ID: 8676971 [No Abstract] [Full Text] [Related]
16. Some patients with HCC haven't abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels. Bertino G, Ardiri AM, Santonocito MM, Boemi PM. Panminerva Med; 2009 Jun 27; 51(2):133-4. PubMed ID: 19776714 [No Abstract] [Full Text] [Related]
17. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M. J Clin Gastroenterol; 2006 Jun 27; 40(10):942-8. PubMed ID: 17063116 [Abstract] [Full Text] [Related]
18. Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers. Iizuka N, Oka M, Sakaida I, Moribe T, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Yamashita S, Okita K, Sakata K, Karino Y, Toyota J, Ando E, Ide T, Sata M, Tsunedomi R, Tsutsui M, Iida M, Tokuhisa Y, Sakamoto K, Tamesa T, Fujita Y, Hamamoto Y. Clin Chim Acta; 2011 Jan 14; 412(1-2):152-8. PubMed ID: 20883676 [Abstract] [Full Text] [Related]
19. [Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation]. Sakaguchi K, Kobayashi Y, Matsumoto E, Shiratori Y. Nihon Rinsho; 2004 Jul 14; 62 Suppl 7(Pt 1):629-33. PubMed ID: 15359874 [No Abstract] [Full Text] [Related]
20. Current approach to hepatocellular carcinoma. Abrams P, Marsh JW. Surg Clin North Am; 2010 Aug 14; 90(4):803-16. PubMed ID: 20637949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]